key: cord-0319435-d6hamdcr
authors: Monterde, D.; Carot-Sans, G.; Cainzos-Achirica, M.; Abilleira, S.; Coca, M.; Vela, E.; Cleries, M.; Valero, D.; Comin-Colet, J.; Garcia-Eroles, L.; Perez-Sust, P.; Arrufat, M.; Lejardi, Y.; Piera-Jimenez, J.
title: Comorbidity accounts for severe COVID-19 risk, but how do we measure it? Retrospective assessment of the performance of three measures of comorbidity using 4,607 hospitalizations
date: 2021-07-06
journal: nan
DOI: 10.1101/2021.07.02.21259898
sha: 55e17795d8a2fec538913edb7e49c2699180a5a1
doc_id: 319435
cord_uid: d6hamdcr

Background: Comorbidity burden has been identified as a relevant predictor of critical illness in patients hospitalized with coronavirus disease 2019 (COVID-19). However, comorbidity burden is often represented by a simple count of few conditions that may not fully capture patients' complexity. Purpose: To evaluate the performance of a comprehensive index of the comorbidity burden (Queralt DxS), which includes all chronic conditions present on admission, as an adjustment variable in models for predicting critical illness in hospitalized COVID-19 patients and compare it with two broadly used measures of comorbidity. Patients and methods: We analyzed data from all COVID-19 hospitalizations reported in eight public hospitals of Catalonia (North-East Spain) between June 15 and December 8 2020. The primary outcome was a composite of critical illness that included the need for invasive mechanical ventilation, transfer to ICU, or in-hospital death. Predictors included age, sex, and comorbidities present on admission measured using three indices: the Charlson index, the Elixhauser index, and the Queralt DxS index for comorbidities on admission. The performance of different fitted models was compared using various indicators, including the area under the receiving operating characteristics curve (AUC). Results: Our analysis included 4,607 hospitalized COVID-19 patients. Of them, 1,315 experienced critical illness. Comorbidities significantly contributed to predicting the outcome in all summary indices used. The AUC for prediction of critical illness was 0.641 (95% CI 0.624-0.660) for the Charlson index, 0.665 (0.645-0.681) for the Elixhauser index, and 0.787 (0.773-0.801) for Queralt DxS. Other metrics of model performance also showed Queralt DxS being consistently superior to the other indices. Conclusion: In our analysis, the ability of comorbidity indices to predict hospital outcomes in hospitalized COVID-19 patients increased with their exhaustivity. The comprehensive Queralt DxS index may improve the accuracy of predictive models for resource allocation and clinical decision-making in the hospital setting.

typically rely on vital signs, laboratory results, comorbidities on admission, and-less 82 frequently-results of imaging techniques. 6 Some of them aimed to assess patients' risk at the 83 time of hospital admission using measures of comorbidity burden, typically based on either 84 unweighted counts of comorbidities or the presence of specific diagnoses from a short (i.e., up to 85 12) list of chronic conditions. 7-14 However, this parsimonious approach may not fully capture 86 patient complexity and the prognostic relevance of other conditions. Alternatively, comorbidity 87 indices (e.g., the Charlson Comorbidity Index 15 and the Elixhauser index 16 ) combine information 88 about several comorbidities into a single score. 17, 18 This yields more complex models with a more 89 challenging interpretation; however, it allows adjusting for multiple factors, likely improving model 90 accuracy. 18 91 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.02.21259898 doi: medRxiv preprint hospitals were excluded from the analysis to ensure the completeness of clinical data during the 116 full index hospitalization. 117

All data were handled according to the General Data Protection Regulation 2016/679 on 118 data protection and privacy for all individuals within the European Union and the local regulatory 119 framework regarding data protection. The independent ethics committee of the Bellvitge 120

Biomedical Research Institute (IDIBELL) approved the study protocol and waived the need for 121 informed consent, as the data were generated as part of routine clinical care and fully de-122 identified for analytic purposes. 123

The study outcome ("critical illness" in patients hospitalized with COVID-19) was a 125 composite that included the need for invasive mechanical ventilation, transfer to the intensive 126 care unit (ICU), or in-hospital death. The need for invasive mechanical ventilation was identified 127 by the presence of any of the following procedures codes recorded in the hospital database for 128 billing purposes: 5A09357, 5A09457, 5A09557, 5A1935Z, 5A1945Z, 5A1955Z, 09HN7BZ, 129 09HN8BZ, 0BH13EZ, 0BH17EZ, 0BH18EZ, and 0CHY7BZ . 130 Potential predictors considered for the analysis included age, sex, and comorbidities 131 present on admission. The latter were measured using three multi-comorbidity indices: the 132 Charlson Comorbidity Index, the Elixhauser Index, and Queralt DxS. In another model, we also 133 used the 27 comorbidities included in the Elixhauser Index, each of them separately. The 134

Charlson and Elixhauser indices were estimated using the ICD-10 coding system proposed by 135 Quan et al. 22 For the Charlson index, diagnostic weights were assigned based on the original 136 formulation by Charlson et al. 15 For the Elixhauser Index, we used the weights proposed by 137 Moore et al. 23 Queralt DxS belongs to a family of three indices for predicting clinical outcomes in 138 hospitalized patients that provides a numerical value from the weighted sum of diagnostics 139 (primary, secondary present on admission, and complications) from a list of 2,119 diagnostic 140 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 6, 2021. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.02.21259898 doi: medRxiv preprint hospitals with COVID-19. Table 1 summarizes the demographic characteristics of the study 168 population according to the incidence of critical illness (i.e., need of invasive mechanical 169 ventilation, transfer to ICU, or death) on admission and/or during the hospitalization. The 170 corresponding comorbidity burden, measured using the three analyzed indices, is shown in Table  171 2. Patients who experienced critical illness on/after admission were significantly older and had 172 higher scores of comorbidity burden irrespective of the index used. Men more frequently 173 experienced critical illness. 174 175 Abbreviations: SD, standard deviation 182 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.02.21259898 doi: medRxiv preprint Table 2 CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.02.21259898 doi: medRxiv preprint The results for AUROCC were consistent with those observed using all other metrics of 214 model performance. In all, the best performance was consistently observed for the model that 215

included age, sex, and Queralt DxS (Figure 2 ). The addition of Queralt DxS to the baseline model 216 of age and sex significantly improved the AUROCC and AUPRC of the model compared with 217 other measures of comorbidity. Figure 3 shows the ROC and precision-recall curves of the five 218 models explored. 219 220 221 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 6, 2021. Indices that summarize a high number of variables into a single numerical index, such as 261

Queralt DxS, also have the advantage of allowing more parsimonious models. This is particularly 262 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 6, 2021. Also, as often occurs in retrospective analyses, our dataset was limited to the data 280 recorded in electronic records during routine care. Nonetheless, the universal coverage of our 281 healthcare system, and the cross-linking of healthcare data from the primary care and specialized 282 settings allowed us to access various sources and very comprehensive health data from our 283 study population and consider all possible diagnostics present on admission, as well as basic 284 demographic data such as age and sex. Conversely, we were not able to include some pre-285 admission variables such as blood groups, which have been associated with COVID-19 severity 36 286 and might modulate the weight of comorbidities when estimating the risk of critical illness, or the 287 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 6, 2021. 

The study protocol was approved by the independent ethics committee of the Bellvitge 306

Biomedical Research Institute (IDIBELL), which waived the need for informed consent, as the 307 data were generated as part of routine clinical care and fully de-identified for analytic purposes. 308 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 6, 2021. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 6, 2021. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 6, 2021. ; https://doi.org/10.1101/2021.07.02.21259898 doi: medRxiv preprint

Current Status of COVID-19 Vaccine Development: 322 Focusing on Antigen Design and Clinical Trials on Later Stages

Risk Factors Associated with Mortality among 325 Patients with COVID-19 in Intensive Care Units in Lombardy, Italy

Risk stratification of patients admitted to hospital with 362 covid-19 using the ISARIC WHO Clinical Characterisation Protocol: Development and 363 29. R Core Team. R: A language and environment for statistical com-puting